期刊文献+

氨氯地平阿托伐他汀钙片对高血压合并冠心病患者血压及血脂水平的影响 被引量:5

Effects of amlodipine and atorvastatin calcium tablets on blood pressure and blood lipid levels in patients with hypertension and coronary heart disease
下载PDF
导出
摘要 目的探讨氨氯地平阿托伐他汀钙片对高血压合并冠心病对患者血压及血脂水平的影响。方法选取2018年1月至2020年3月我院收治的82例高血压合并冠心病患者,根据随机数字表法将其分为对照组和观察组,各41例。对照组给予氨氯地平治疗,观察组给予氨氯地平阿托伐他汀钙片治疗。比较两组治疗前、后的血压、血脂指标、血液流变学指标、血管内皮功能指标及C反应蛋白水平。结果治疗前,两组SBP、DBP、TC、TG、LDL-C、ESR、HCT、PV、血管内皮素、一氧化氮、C反应蛋白比较,差异无统计学意义(P>0.05)。治疗后,两组SBP、DBP、TC、TG、LDL-C、ESR、HCT、PV均较治疗前降低,且观察组低于对照组,差异具有统计学意义(P<0.05)。治疗后,两组血管内皮素、C反应蛋白水平均较治疗前降低,一氧化氮较治疗前升高,且观察组优于对照组(P<0.05)。结论氨氯地平阿托伐他汀钙片可提高对高血压合并冠心病患者血压和血脂的控制效果,改善血液流变学,减轻血管内皮功能损伤和炎症反应。 Objective To investigate the effects of amlodipine and atorvastatin calcium tablets on blood pressure and blood lipid levels in patients with hypertension and coronary heart disease.Methods A total of 82 patients with hypertension and coronary heart disease admitted in our hospital from January 2018 to March 2020 were selected and divided into control group and observation group according to random number table,with 41 cases in each group.The control group was treated with amlodipine,and the observation group was treated with amlodipine and atorvastatin calcium tablets.The blood pressure,blood lipid indexes,hemorheology indexes,vascular endothelial function indexes and C-reactive protein levels were compared between the two groups before and after treatment.Results Before treatment,there were no significant differences in SBP,DBP,TC,TG,LDL-C,ESR,HCT,PV,endothelin,NO and CRP levels between the two groups(P>0.05).After treatment,SBP,DBP,TC,TG,LDL-C,ESR,HCT and PV in the two groups were lower than those before treatment,those in the observation group were lower than the control group,and the differences were statistically significant(P<0.05).After treatment,the levels of endothelin and C-reactive protein in the two groups were lower than those before treatment,the level of NO was higher than that before treatment,and those in the observation group were better than the control group(P<0.05).Conclusion Amlodipine and atorvastatin calcium tablets in the treatment of patients with hypertension and coronary heart disease can improve the control effects of blood pressure and blood lipid,ameliorate hemorheology,and reduce vascular endothelial function damage and inflammatory reaction.
作者 冯丽芳 FENG Lifang(Pharmacy Department,the People's Hospital of Qi County,Hebi 456750,China)
出处 《临床医学研究与实践》 2021年第6期58-59,62,共3页 Clinical Research and Practice
关键词 高血压 冠心病 氨氯地平阿托伐他汀钙片 血压 血脂 hypertension coronary heart disease amlodipine atorvastatin calcium tablets blood pressure blood lipid
  • 相关文献

参考文献8

二级参考文献82

  • 1周磊,吕远,张小勇.硝苯地平联合依那普利治疗老年冠心病合并高血压的疗效[J].中国老年学杂志,2014,34(5):1389-1390. 被引量:43
  • 2无.血管紧张素转换酶抑制剂在心血管病中应用中国专家共识[J].中华心血管病杂志,2007,35(2):97-106. 被引量:133
  • 3Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery ( EACTS ), European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, et al. Guidelines on myocardial revascularization. Eur Heart J,2010 , 31:2501-2555. 被引量:1
  • 4Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/ SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation, 2011, 124 :e574-651. 被引量:1
  • 5Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery. A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coil Cardiol, 2011,58 :e123-210. 被引量:1
  • 6Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk evaluation ( EuroSCORE ). Eur J Cardiothorac Surg, 1999,16:9-13. 被引量:1
  • 7Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med, 2009,360:961- 972. 被引量:1
  • 8Peterson ED, Dai D, DeLong ER, et al. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coil Cardiol,2010,55:1923-1932. 被引量:1
  • 9Online STS fish calculator [ S/OL]. [ 2012-01-01 ]. http:// riskcalc, sts. org/STSWebRiskCalc273/de, aspx. 被引量:1
  • 10Mehta SR, Tanguay JF, Eikelboom JW, et al. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes ( CURRENT-OASIS 7 ): a randomised factorial trial. Lancet,2010,376 : 1233-1243. 被引量:1

共引文献814

同被引文献51

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部